• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Virtual Second Opinions on the Rise: Cardiology, Cancer, and Neurology Lead the Way

by Fred Pennic 09/17/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– A new study by The Clinic by Cleveland Clinic has shed light on the increasing demand for virtual second opinions (VSOs) in the US, with a particular focus on heart, cancer, and neurological conditions.

– This trend underscores the growing need for accessible specialty care, especially in regions facing healthcare provider shortages.

Specialty Care Deserts Drive VSO Demand

The national shortage of healthcare providers has created “specialty care deserts,” particularly in rural areas. This lack of access to specialists, combined with an aging population and increasing prevalence of chronic diseases, is driving patients to seek VSOs. The study found that cardiology and cancer cases accounted for the largest share of VSOs nationally.

Regional Variations

While heart and cancer cases dominated VSO requests across most regions, the Midwest saw a higher proportion of cancer-related VSOs, likely due to The Clinic’s health plan partnerships in the area.

  • Midwest: 44% of all cases, with 38% related to cancer and 21% to cardiology
  • South: 24% of cases, with 32% related to cardiology and 20% to cancer
  • Northeast: 18% of cases, with 32% related to cardiology and 20% to cancer
  • West: 14% of cases, with 32% related to cardiology and 20% to cancer
  • Other common VSO areas: neurological, digestive, and urological/kidney concerns
  • West-specific trend: orthopedic and rheumatologic VSOs were more common than urological/kidney

The Value of Virtual Second Opinions

The Clinic’s data highlights the significant benefits of VSOs. Beyond providing access to world-class specialists, VSOs lead to an average cost saving of $8,705 per patient. Moreover, VSOs are more likely to recommend alternative treatments to surgery and reduce hospitalization rates compared to initial care plans.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |